Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addiction. Here we show that a selective aldehyde dehydrogenase-2 (ALDH-2) inhibitor, ALDH2i, suppresses cocaine self-administration in rats and prevents cocaine- or cue-induced reinstatement in a rat model of cocaine relapse-like behavior. We also identify a molecular mechanism by which ALDH-2 inhibition reduces cocaine-seeking behavior: increases in tetrahydropapaveroline (THP) formation due to inhibition of ALDH-2 decrease cocaine-stimulated dopamine production and release in vitro and in vivo. Cocaine increases extracellular dopamine concentration, which activates dopamine D2 autoreceptors to stimulate cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC) in primary ventral tegmental area (VTA) neurons. PKA and PKC phosphorylate and activate tyrosine hydroxylase, further increasing dopamine synthesis in a positive-feedback loop. Monoamine oxidase converts dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL), a substrate for ALDH-2. Inhibition of ALDH-2 enables DOPAL to condense with dopamine to form THP in VTA neurons. THP selectively inhibits phosphorylated (activated) tyrosine hydroxylase to reduce dopamine production via negative-feedback signaling. Reducing cocaine- and craving-associated increases in dopamine release seems to account for the effectiveness of ALDH2i in suppressing cocaine-seeking behavior. Selective inhibition of ALDH-2 may have therapeutic potential for treating human cocaine addiction and preventing relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388 · cited 1×
“2200" language="eng" relation="no"> There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addictio”
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 1×
“2200" language="eng" relation="no"> There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addictio”
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072 · cited 1×
“ALDH-2 converts DOPAL to 3,4-dihydroxyphenyl-acetic acid (DOPAC”
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Tyrosine hydroxylase phosphorylation: Regulation and consequences
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02797.x · Cited by 455
Roberts, D. C. S., & Koob, G. F. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90469-5 · Cited by 448
The Status of Disulfiram: A Half of a Century Later
Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222512.25649.08 · Cited by 382 · cited 1×
“Recent anecdotal clinical reports suggest that disulfiram may attenuate cocaine us”
The Neurobiology of Cocaine Addiction
Nestler, E. (2005) · Science & Practice Perspectives · doi:10.1151/spp05314 · Cited by 367
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Research works printed but not linked: 31
- Volkow, N.D. & Li, T.K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 5, 963–970 (2004). · DOI · Paper page
- Sofuoglu, M. & Kosten, T.R. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin. Emerg. Drugs 11, 91–98 (2006). · DOI · Paper page
- Gaval-Cruz, M. & Weinshenker, D. Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol. Interv. 9, 175–187 (2009). · DOI · Paper page
- Arolfo, M.P. et al. Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol. Clin. Exp. Res. 33, 1935–1944 (2009). · DOI
- Keung, W.M., Lazo, O., Kunze, L. & Vallee, B.L. Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. Proc. Natl. Acad. Sci. USA 92, 8990–8993 (1995). · doi:10.1073/pnas.92.19.8990
- Bossert, J.M., Ghitza, U.E., Lu, L., Epstein, D.H. & Shaham, Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur. J. Pharmacol. 526, 36–50 (2005). · DOI · Paper page
- Hyman, S.E. & Malenka, R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695–703 (2001). · DOI · Paper page
- Balter, M. New clues to brain dopamine control, cocaine addiction. Science 271, 909 (1996). · doi:10.1126/science.271.5251.909
- Berke, J.D. & Hyman, S.E. Addiction, dopamine and the molecular mechanisms of memory. Neuron 25, 515–532 (2000). · DOI · Paper page
- McCaffery, P. & Drager, U.C. High levels of a retinoic acid–generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. USA 91, 7772–7776 (1994). · DOI · Paper page
- Lamensdorf, I. et al. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res. 868, 191–201 (2000). · DOI
- Marchitti, S.A., Deitrich, R.A. & Vasiliou, V. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev. 59, 125–150 (2007). · DOI · Paper page
- Kim, Y.M., Kim, M.N., Lee, J.J. & Lee, M.K. Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386, 1–4 (2005). · doi:10.1016/j.neulet.2005.04.105
- Brodie, M.S. & Dunwiddie, T.V. Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 342, 660–665 (1990). · DOI
- Chen, S.Y., Burger, R.I. & Reith, M.E. Extracellular dopamine in the rat ventral tegmental area and nucleus accumbens following ventral tegmental infusion of cocaine. Brain Res. 729, 294–296 (1996). · DOI
- Lacey, M.G., Mercuri, N.B. & North, R.A. Actions of cocaine on rat dopaminergic neurones in vitro. Br. J. Pharmacol. 99, 731–735 (1990). · DOI · Paper page
- Yao, L. et al. Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol. Pharmacol. 73, 1105–1112 (2008). · DOI
- Stuber, G.D. et al. Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons. Science 321, 1690–1692 (2008). · DOI · Paper page
- Myers, R.D. Anatomical 'circuitry' in the brain mediating alcohol drinking revealed by THP-reactive sites in the limbic system. Alcohol 7, 449–459 (1990). · doi:10.1016/0741-8329(90)90031-7
- Sombers, L.A., Beyene, M., Carelli, R.M. & Wightman, R.M. Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J. Neurosci. 29, 1735–1742 (2009). · DOI · Paper page
- Dickinson, S.D. et al. Dopamine D2 receptor–deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148–156 (1999). · DOI · Paper page
- Hahn, J., Kullmann, P.H., Horn, J.P. & Levitan, E.S. D2 autoreceptors chronically enhance dopamine neuron pacemaker activity. J. Neurosci. 26, 5240–5247 (2006). · DOI
- Negus, S.S., Mello, N.K., Lamas, X. & Mendelson, J.H. Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 278, 879–890 (1996). · DOI
- Rassnick, S., Pulvirenti, L. & Koob, G.F. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl.) 109, 92–98 (1992). · DOI · Paper page
- Saeedi, H., Remington, G. & Christensen, B.K. Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. Schizophr. Res. 85, 222–231 (2006). · DOI
- Tinsley, R.B. et al. Dopamine D2 receptor knockout mice develop features of Parkinson disease. Ann. Neurol. 66, 472–484 (2009). · DOI
- Inoue, Y. et al. Nicotine and ethanol activate protein kinase A synergistically via Gi βγ subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D1/D2 and adenosine A2A receptors. J. Pharmacol. Exp. Ther. 322, 23–29 (2007). · DOI
- Yamauchi, T. & Fujisawa, H. A simple and sensitive fluorometric assay for tyrosine hydroxylase. Anal. Biochem. 89, 143–150 (1978). · doi:10.1016/0003-2697(78)90735-2
- Sherald, A.F., Sparrow, J.C. & Wright, T.R. A spectrophotometric assay for Drosophila dopa decarboxylase. Anal. Biochem. 56, 300–305 (1973). · doi:10.1016/0003-2697(73)90194-2
- Nagatsu, T. & Udenfriend, S. Photometric assay of dopamine-β-hydroxylase activity in human blood. Clin. Chem. 18, 980–983 (1972). · DOI · Paper page
- McFarland, K., Davidge, S.B., Lapish, C.C. & Kalivas, P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24, 1551–1560 (2004). · DOI · Paper page
Cited by
Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614
Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005538 · Cited by 557
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase
Kosten, T. R., Wu, G., Huang, W., Harding, M. J., Hamon, S. C., Lappalainen, J., & Nielsen, D. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.011 · Cited by 108
Schottenfeld, R. S., Chawarski, M. C., Cubells, J. F., George, T. P., Lappalainen, J., & Kosten, T. R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.12.007 · Cited by 31
Metadata
- Authors
- Yao, L., Fan, P., Arolfo, M., Jiang, Z., Olive, M. F., Zablocki, J., Sun, H.-L., Chu, N., Lee, J., Kim, H.-Y., Leung, K., Shryock, J., Blackburn, B., & Diamond, I.
- Venue
- Nature Medicine
- Published
- 2010-08-22
- Volume
- 16
- Issue
- 9
- Pages
- 1024-1028
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2007792880
- Cited by
- 97
- References
- 10
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Update notices
- addendum (2011-02-04)
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis. https://app.cochat.ai/papers/10.1038/nm.2200
- The paper
- Yao, L., Fan, P., Arolfo, M., Jiang, Z., Olive, M. F., Zablocki, J., Sun, H.-L., Chu, N., Lee, J., Kim, H.-Y., Leung, K., Shryock, J., Blackburn, B., & Diamond, I. (2010). Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis. Nature Medicine. https://doi.org/10.1038/nm.2200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.